하부 호흡기 치료제 시장 : 세계 산업 규모, 점유율, 동향, 기회, 예측, 질환 유형별, 약제 클래스별, 투여 경로별, 최종사용자별, 지역별, 경쟁(2020-2030년)
Lower Respiratory Tract Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Disease Type, By Drug Class, By Route of Administration, By End User, By Region and Competition, 2020-2030F
상품코드:1667898
리서치사:TechSci Research
발행일:2025년 02월
페이지 정보:영문 185 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
하부 호흡기 치료제 세계 시장 규모는 2024년 360억 4,000만 달러에서 2030년에는 589억 8,000만 달러에 달할 것으로 예상되며, 연평균 성장률(CAGR)은 8.53%를 나타낼 것으로 예상됩니다.
폐렴, 기관지염, 만성폐쇄성폐질환(COPD)과 같은 호흡기 질환의 유병률 증가와 같은 주요 요인이 시장 성장의 원동력이 되고 있습니다. 특히 고령자나 면역력이 약한 취약계층에서 이러한 질환의 세계적 부담이 증가함에 따라 효과적인 치료 옵션에 대한 수요가 증가하고 있습니다. 또한 많은 지역에서 도시화, 환경오염물질 노출, 흡연율 증가로 인해 이러한 질환의 발생이 더욱 악화되고 있으며, 이는 급성 및 만성 호흡기 감염을 치료할 수 있는 치료제의 필요성을 높이고 있습니다. 또한, 특히 신흥국 시장의 의료 인프라 확충은 진단 및 치료 접근성을 높여 호흡기 치료 시장 확대에 기여하고 있습니다.
시장 개요
예측 기간
2026-2030년
시장 규모 : 2024년
360억 4,000만 달러
시장 규모 : 2030년
589억 8,000만 달러
CAGR(2025-2030년)
8.53%
급성장 부문
병원 클리닉
최대 시장
북미
주요 시장 성장 촉진요인
주요 시장 과제
주요 시장 동향 :
목차
제1장 개요
제2장 조사 방법
제3장 주요 요약
제4장 COVID-19가 세계의 하부 호흡기 치료제 시장에 미치는 영향
제5장 고객의 소리
제6장 세계의 하부 호흡기 치료제 시장 전망
시장 규모와 예측
금액별
시장 점유율과 예측
질환 유형별(천식, COPD, 폐렴, 결핵, 기관지염, 기타)
약제 클래스별(항생제, 비스테로이드성 항염증제, 기침약, 코막힘약, 기타)
투여 경로별(경구, 비경구, 기타)
최종사용자별(병원 클리닉, 외래 진료 센터, 기타)
지역별
기업별(2024년)
시장 맵
제7장 아시아태평양의 하부 호흡기 치료제 시장 전망
시장 규모와 예측
시장 점유율과 예측
아시아태평양 : 국가별 분석
인도
호주
일본
한국
제8장 유럽의 하부 호흡기 치료제 시장 전망
시장 규모와 예측
시장 점유율과 예측
유럽 : 국가별 분석
독일
스페인
이탈리아
영국
제9장 북미의 하부 호흡기 치료제 시장 전망
시장 규모와 예측
시장 점유율과 예측
북미 : 국가별 분석
멕시코
캐나다
제10장 남미의 하부 호흡기 치료제 시장 전망
시장 규모와 예측
시장 점유율과 예측
남미 : 국가별 분석
아르헨티나
콜롬비아
제11장 중동 및 아프리카의 하부 호흡기 치료제 시장 전망
시장 규모와 예측
시장 점유율과 예측
중동 및 아프리카 : 국가별 분석
사우디아라비아
아랍에미리트(UAE)
제12장 시장 역학
성장 촉진요인
과제
제13장 시장 동향과 발전
제품 출시
인수합병(M&A)
제14장 세계의 하부 호흡기 치료제 시장 : SWOT 분석
제15장 Porter의 Five Forces 분석
산업내 경쟁
신규 참여 가능성
공급업체의 힘
고객의 힘
대체품의 위협
제16장 PESTEL 분석
제17장 경쟁 구도
F. Hoffman-La Roche Ltd
Teva Pharmaceutical Industries Ltd.
Sanofi S.A
Pfizer Inc.
GSK plc
Novartis AG
AstraZeneca
Johnson & Johnson
Sun Pharmaceutical Industries Ltd.
Merck & Co., Inc
제18장 전략적 제안
제19장 리서치사에 대해 & 면책사항
LSH
영문 목차
영문목차
The Global Lower Respiratory Tract Therapeutics Market was valued at USD 36.04 billion in 2024 and is projected to reach USD 58.98 billion by 2030, registering a Compound Annual Growth Rate (CAGR) of 8.53%. This market growth is driven by key factors such as the rising prevalence of respiratory diseases like pneumonia, bronchitis, and chronic obstructive pulmonary disease (COPD). The increasing global burden of these conditions, particularly among vulnerable groups like the elderly and immunocompromised individuals, has fueled the demand for effective treatment options. Additionally, urbanization, exposure to environmental pollutants, and higher smoking rates in many regions are further aggravating the incidence of these diseases, which in turn drives the need for therapeutics to address both acute and chronic respiratory infections. The expansion of healthcare infrastructure, especially in developing regions, has also enhanced the accessibility of diagnoses and treatments, contributing to a growing market for respiratory therapeutics.
Market Overview
Forecast Period
2026-2030
Market Size 2024
USD 36.04 Billion
Market Size 2030
USD 58.98 Billion
CAGR 2025-2030
8.53%
Fastest Growing Segment
Hospitals & Clinics
Largest Market
North America
Key Market Drivers:
Rising Prevalence of Respiratory Disorders The global healthcare landscape is seeing a notable rise in respiratory disorders, particularly lower respiratory tract conditions. Disorders such as chronic obstructive pulmonary disease (COPD), asthma, pneumonia, and bronchitis are becoming more widespread, leading to heightened demand for effective therapeutic solutions. Lower respiratory tract conditions, which significantly affect lung function and overall quality of life, are among the most prevalent and debilitating. These conditions are becoming increasingly common, driven by factors such as urbanization, pollution, tobacco use, and sedentary lifestyles, alongside an aging population more susceptible to respiratory health issues.
Key Market Challenges:
Competition from Generic Drugs The market for lower respiratory tract therapeutics faces considerable challenges from intense competition and the growing availability of generic drugs. As branded therapies become established, generic alternatives often enter the market, offering more cost-effective options for patients. This price competition places pressure on pharmaceutical companies, particularly those marketing patented treatments, as generics provide comparable therapeutic effects at a much lower cost. The widespread use of generic drugs plays a pivotal role in reducing healthcare costs, posing a challenge for branded drug manufacturers to retain market share.
Key Market Trends:
Shift Towards Targeted Therapies There is a significant trend toward the development of targeted therapies in the global lower respiratory tract therapeutics market. This shift is driven by advancements in molecular biology and a deeper understanding of disease mechanisms. Targeted therapies aim to address the root causes of diseases such as COPD and asthma, rather than just alleviating symptoms. For example, biologic agents like monoclonal antibodies are being developed to target specific inflammatory molecules such as interleukins, which are integral in diseases like asthma and COPD. These treatments offer enhanced precision by directly addressing the underlying mechanisms of disease.
Key Market Players:
F. Hoffmann-La Roche Ltd.
Teva Pharmaceutical Industries Ltd.
Sanofi S.A.
Pfizer Inc.
GSK plc
Novartis AG
AstraZeneca Inc.
Johnson & Johnson
Sun Pharmaceutical Industries Ltd.
Merck & Co., Inc.
Report Scope:
This report segments the Global Lower Respiratory Tract Therapeutics Market into the following categories, with detailed industry trends:
By Disease Type:
Asthma
COPD
Pneumonia
Tuberculosis
Bronchitis
Others
By Drug Class:
Antibiotics
Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
Cough Suppressants
Nasal Decongestants
Others
By Route of Administration:
Oral
Parenteral
Others
By End User:
Hospitals & Clinics
Ambulatory Care Centers
Others
By Region:
North America (United States, Canada, Mexico)
Europe (France, United Kingdom, Italy, Germany, Spain)
Asia-Pacific (China, India, Japan, Australia, South Korea)
South America (Brazil, Argentina, Colombia)
Middle East & Africa (South Africa, Saudi Arabia, UAE)
Competitive Landscape:
Company Profiles: This section provides a detailed analysis of the major companies operating in the Lower Respiratory Tract Therapeutics Market.
Available Customizations:
The Global Lower Respiratory Tract Therapeutics Market report offers customizations tailored to the specific needs of a company. The following customization options are available:
Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Applications
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Impact of COVID-19 on Global Lower Respiratory Tract Therapeutics Market
5. Voice of Customer
6. Global Lower Respiratory Tract Therapeutics Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Disease Type (Asthma, COPD, Pneumonia, Tuberculosis, Bronchitis, Others)
6.2.2. By Drug Class (Antibiotics, Non-Steroidal Anti-Inflammatory Drugs, Cough Suppressants, Nasal Decongestants, Others)
6.2.3. By Route of Administration (Oral, Parenteral, Others)
6.2.4. By End User (Hospitals & Clinics, Ambulatory Care Centres, Others)
6.2.5. By Region
6.2.6. By Company (2024)
6.3. Market Map
7. Asia Pacific Lower Respiratory Tract Therapeutics Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Disease Type
7.2.2. By Drug Class
7.2.3. By Route of Administration
7.2.4. By End User
7.2.5. By Country
7.3. Asia Pacific: Country Analysis
7.3.1. China Lower Respiratory Tract Therapeutics Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Disease Type
7.3.1.2.2. By Drug Class
7.3.1.2.3. By Route of Administration
7.3.1.2.4. By End User
7.3.2. India Lower Respiratory Tract Therapeutics Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Disease Type
7.3.2.2.2. By Drug Class
7.3.2.2.3. By Route of Administration
7.3.2.2.4. By End User
7.3.3. Australia Lower Respiratory Tract Therapeutics Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Disease Type
7.3.3.2.2. By Drug Class
7.3.3.2.3. By Route of Administration
7.3.3.2.4. By End User
7.3.4. Japan Lower Respiratory Tract Therapeutics Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Disease Type
7.3.4.2.2. By Drug Class
7.3.4.2.3. By Route of Administration
7.3.4.2.4. By End User
7.3.5. South Korea Lower Respiratory Tract Therapeutics Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Disease Type
7.3.5.2.2. By Drug Class
7.3.5.2.3. By Route of Administration
7.3.5.2.4. By End User
8. Europe Lower Respiratory Tract Therapeutics Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Disease Type
8.2.2. By Drug Class
8.2.3. By Route of Administration
8.2.4. By End User
8.2.5. By Country
8.3. Europe: Country Analysis
8.3.1. France Lower Respiratory Tract Therapeutics Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Disease Type
8.3.1.2.2. By Drug Class
8.3.1.2.3. By Route of Administration
8.3.1.2.4. By End User
8.3.2. Germany Lower Respiratory Tract Therapeutics Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Disease Type
8.3.2.2.2. By Drug Class
8.3.2.2.3. By Route of Administration
8.3.2.2.4. By End User
8.3.3. Spain Lower Respiratory Tract Therapeutics Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Disease Type
8.3.3.2.2. By Drug Class
8.3.3.2.3. By Route of Administration
8.3.3.2.4. By End User
8.3.4. Italy Lower Respiratory Tract Therapeutics Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Disease Type
8.3.4.2.2. By Drug Class
8.3.4.2.3. By Route of Administration
8.3.4.2.4. By End User
8.3.5. United Kingdom Lower Respiratory Tract Therapeutics Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Disease Type
8.3.5.2.2. By Drug Class
8.3.5.2.3. By Route of Administration
8.3.5.2.4. By End User
9. North America Lower Respiratory Tract Therapeutics Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Disease Type
9.2.2. By Drug Class
9.2.3. By Route of Administration
9.2.4. By End User
9.2.5. By Country
9.3. North America: Country Analysis
9.3.1. United States Lower Respiratory Tract Therapeutics Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Disease Type
9.3.1.2.2. By Drug Class
9.3.1.2.3. By Route of Administration
9.3.1.2.4. By End User
9.3.2. Mexico Lower Respiratory Tract Therapeutics Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Disease Type
9.3.2.2.2. By Drug Class
9.3.2.2.3. By Route of Administration
9.3.2.2.4. By End User
9.3.3. Canada Lower Respiratory Tract Therapeutics Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Disease Type
9.3.3.2.2. By Drug Class
9.3.3.2.3. By Route of Administration
9.3.3.2.4. By End User
10. South America Lower Respiratory Tract Therapeutics Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Disease Type
10.2.2. By Drug Class
10.2.3. By Route of Administration
10.2.4. By End User
10.2.5. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Lower Respiratory Tract Therapeutics Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Disease Type
10.3.1.2.2. By Drug Class
10.3.1.2.3. By Route of Administration
10.3.1.2.4. By End User
10.3.2. Argentina Lower Respiratory Tract Therapeutics Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Disease Type
10.3.2.2.2. By Drug Class
10.3.2.2.3. By Route of Administration
10.3.2.2.4. By End User
10.3.3. Colombia Lower Respiratory Tract Therapeutics Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Disease Type
10.3.3.2.2. By Drug Class
10.3.3.2.3. By Route of Administration
10.3.3.2.4. By End User
11. Middle East and Africa Lower Respiratory Tract Therapeutics Market Outlook
11.1. Market Size & Forecast
11.1.1. By Value
11.2. Market Share & Forecast
11.2.1. By Disease Type
11.2.2. By Drug Class
11.2.3. By Route of Administration
11.2.4. By End User
11.2.5. By Country
11.3. MEA: Country Analysis
11.3.1. South Africa Lower Respiratory Tract Therapeutics Market Outlook
11.3.1.1. Market Size & Forecast
11.3.1.1.1. By Value
11.3.1.2. Market Share & Forecast
11.3.1.2.1. By Disease Type
11.3.1.2.2. By Drug Class
11.3.1.2.3. By Route of Administration
11.3.1.2.4. By End User
11.3.2. Saudi Arabia Lower Respiratory Tract Therapeutics Market Outlook
11.3.2.1. Market Size & Forecast
11.3.2.1.1. By Value
11.3.2.2. Market Share & Forecast
11.3.2.2.1. By Disease Type
11.3.2.2.2. By Drug Class
11.3.2.2.3. By Route of Administration
11.3.2.2.4. By End User
11.3.3. UAE Lower Respiratory Tract Therapeutics Market Outlook
11.3.3.1. Market Size & Forecast
11.3.3.1.1. By Value
11.3.3.2. Market Share & Forecast
11.3.3.2.1. By Disease Type
11.3.3.2.2. By Drug Class
11.3.3.2.3. By Route of Administration
11.3.3.2.4. By End User
12. Market Dynamics
12.1. Drivers
12.2. Challenges
13. Market Trends & Developments
13.1. Recent Developments
13.2. Product Launches
13.3. Mergers & Acquisitions
14. Global Lower Respiratory Tract Therapeutics Market: SWOT Analysis
